We serve the states of Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, Ohio and Wisconsin.
Ending the HIV Epidemic in the Midwest
MATEC is enhancing the capacity of health care professionals to end the HIV epidemic throughout the Midwest as a funded partner of the national Ending the HIV Epidemic: A Plan for America initiative.
Latest News
FDA Approves First Injectable Treatment for #HIV Pre-Exposure Prevention (PrEP)
On December 10, 2021, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV. Apretude is given first as two initiation injections administered one month apart, and then every…
Updates to Perinatal HIV Clinical Guidelines
January 5, 2022: The Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission recently updated several sections of the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. The following sections were among those updated: Maternal HIV Testing and Identification of Perinatal…
Updates to the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV
This notice updates and corrects an announcement on this subject sent January 20, 2022. The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the following sections of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Highlights are summarized below: Early (Acute and Recent) HIV Infection…
CONNECT WITH US
MATEC Regional Headquarters
University of Illinois College of Medicine
Department of Family and Community Medicine
1919 W. Taylor Street (MC779), 8th Floor
Chicago, IL 60612